Stay updated on Sitravatinib Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Sitravatinib Combo in Advanced NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a non-content site update.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision: v3.5.2 has been released, replacing v3.5.0. This update appears to be a backend version change with no visible changes to the study page or user-facing features.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check41 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check77 days agoChange Detected- Deployed version v3.4.2, replacing v3.4.1. - No visible changes to core study details, eligibility criteria, or results data.SummaryDifference0.1%

- Check84 days agoChange DetectedA revision entry updated from v3.4.0 to v3.4.1, with no substantive content changes indicated. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

Stay in the know with updates to Sitravatinib Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo in Advanced NSCLC Clinical Trial page.